Trexquant Investment LP Foghorn Therapeutics Inc. Transaction History

Trexquant Investment LP

  • $6.33 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$4.66 - $8.99 $102,394 - $197,537
-21,973 Reduced 60.61%
14,283 $88,000
Q4 2022

Feb 13, 2023
BUY
$5.44 - $9.46 $76,480 - $132,998
14,059 Added 63.34%
36,256 $231,000
Q3 2022

Nov 14, 2022
BUY
$7.52 - $18.01 $166,921 - $399,767
22,197 New
22,197 $190,000

Others Institutions Holding FHTX

# of Institutions
72
Shares Held
32.7M
Call Options Held
6K
Put Options Held
1.8K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email